Together, the Chinese-made Sinopharm and Sinovac vaccines account for almost half of the 7.3 billion COVID-19 vaccines that have been delivered to date around the world, especially to developing regions in Asia and Latin America (not so much in Africa).
But the overwhelming majority of those Chinese vaccine distributions are in the form of sales, not donations, a point picked up on by the United States in its recent announcement that it had donated 200 million doses to more than 100 developing countries.
